Induced pluripotent stem cell generation-associated point mutationsy

DOI Web Site 13 References Open Access
  • Araki Ryoko
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
  • Sugiura Mayumi
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
  • Hoki Yuko
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
  • Sunayama Misato
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
  • Nakamura Miki
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
  • Kasama Yasuji
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan
  • Abe Masumi
    Transcriptome Research Group, National Institute of Radiological Sciences, Chiba, Japan

Search this article

Description

The discovery of induced pluripotent stem cells (iPSCs) has the potential to drastically alter the future of medicine. Further, the achievement of cell lineage conversion by gene transduction is expected to make a dramatic contribution to the advancement of basic biology. Currently, various iPSC applications have been the focus of much attention due to their potential in regenerative medicine. Nevertheless, because the molecular mechanisms underlying the creation of these cells have remained elusive, confidence in their safe use in a clinical setting has remained rather shaky. In our present review, we discuss genome integrity during iPSC generation, with a particular focus on point mutations, to further address the issue of whether iPSC generation causes genetic aberrations.

Journal

References(13)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top